Pulmonx Corporation

Pulmonx Corporationverified

LUNG

Price:

$9

Market Cap:

$349.34M

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help iden...[Read more]

Industry

Medical - Devices

IPO Date

2020-10-01

Stock Exchange

NASDAQ

Ticker

LUNG

The PE Ratio as of May 2024 (TTM) for Pulmonx Corporation (LUNG) is -5.84

According to Pulmonx Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -5.84. This represents a change of -20.77% compared to the average of -7.37 of the last 4 quarters.

Pulmonx Corporation (LUNG) Historical PE Ratio (quarterly & annually)

How has LUNG PE Ratio performed in the past?

The mean historical PE Ratio of Pulmonx Corporation over the last ten years is -37.47. The current -5.84 PE Ratio has changed 1.46% with respect to the historical average. Over the past ten years (40 quarters), LUNG's PE Ratio was at its highest in in the December 2022 quarter at -5.52. The PE Ratio was at its lowest in in the September 2020 quarter at -86.37.

Quarterly (TTM)
Annual

Average

-37.47

Median

-33.93

Minimum

-76.44

Maximum

-5.31

Pulmonx Corporation (LUNG) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Pulmonx Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 52.69%

Maximum Annual PE Ratio = -5.31

Minimum Annual Increase = -77.71%

Minimum Annual PE Ratio = -76.44

Quarterly (TTM)
Annual
YearPE RatioChange
2023-7.9649.94%
2022-5.31-77.71%
2021-23.81-68.85%
2020-76.4413.63%
2019-67.2652.69%

Pulmonx Corporation (LUNG) Average PE Ratio

How has LUNG PE Ratio performed in the past?

The current PE Ratio of Pulmonx Corporation (LUNG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-12.36

5-year avg

-36.16

10-year avg

-37.47

Pulmonx Corporation (LUNG) PE Ratio vs. Peers

How is LUNG’s PE Ratio compared to its peers?

Pulmonx Corporation’s PE Ratio is less than IRadimed Corporation (29.69), less than Orthofix Medical Inc. (-4.48), greater than NeuroPace, Inc. (-7.33), less than Integer Holdings Corporation (41.27), less than NuVasive, Inc. (68.48), less than CONMED Corporation (27.93), greater than OrthoPediatrics Corp. (-33.26), greater than SI-BONE, Inc. (-14.17), greater than RxSight, Inc. (-50.22), greater than AxoGen, Inc. (-12.27), less than Treace Medical Concepts, Inc. (-5.64), less than ProSomnus, Inc. Common Stock (-0.30), greater than LivaNova PLC (-105.40), less than Electromed, Inc. (32.22), less than Surmodics, Inc. (36.29), less than Inogen, Inc. (-2.14), less than Apyx Medical Corporation (-2.43),

Build a custom stock screener for Pulmonx Corporation (LUNG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pulmonx Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pulmonx Corporation (LUNG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pulmonx Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Pulmonx Corporation's PE Ratio?

How is the PE Ratio calculated for Pulmonx Corporation (LUNG)?

What is the highest PE Ratio for Pulmonx Corporation (LUNG)?

What is the 3-year average PE Ratio for Pulmonx Corporation (LUNG)?

What is the 5-year average PE Ratio for Pulmonx Corporation (LUNG)?

How does the current PE Ratio for Pulmonx Corporation (LUNG) compare to its historical average?